Argyll Free Press

Growing News Network

Saturday, October 16, 2021
Log in

Yes! All Dinosaurs Had Feathers – Says Siberian

By Leave a Comment

Previously, reports have shown that avian dinosaurs have feathers since they are from the breed of modern birds. The new turn in this research is that, all dinosaurs had feathers and this news is definitely confirmed through the fossils of dinosaurs found in Siberia known as ornithiscians

download

This discovery of fossilized features have changed the understanding of researchers regarding when and from where feathers grown. In Siberia, some researchers found out that these dinosaur was plant eaters.

These verdicts show that dinosaurs had feathers which they used for the purpose attracting mates and insulation. However, these functions are unverified. They lived approximately 175 and 145 million years ago in Siberia in the Jurassic era.

Pascal Godefroit, the study leader of the Royal Belgian Institute of Natural Sciences, said that no doubt they had feathers but still they do not have a single characteristic common between birds and these dinosaurs. Furthermore, he described their appearance and stated that those dinosaurs were almost 5 feet in length with long legs and short arms.

According to Godefroit, this development in research of dinosaurs proved that not merely birds contain feathers but in early ages dinosaurs also have had them.

Samsung – Smart Phone Having Tizen OS

By Leave a Comment

Samsung’s effort to take over Indian and Russian smart phones market by developing smart phones based on their home ground operating software – Tizen.

The effort is to push the demand of smart phones and enhance the customer experience by introducing something new. Currently, the major chunk is with Android and Windows OS based smart phones.

To introduce and show case very first Tizen based smart phone, Samsung is planning to manage an event in Moscow in this month. “The launch in Russia would be presented at an ‘Unpacked’ event, similar to the format that Samsung uses to unveil its flagship devices,” said by company’s representator.

ti

Surely the strategy is to differentiate and challenges Google who is currently the “King of the Castle” and of course also to create a distinct identity of Samsung.

To reduce the dependency on Google Android the step of introducing Tizen OS based smart phone is considering good for Samsung by the industry experts but the real thing will only be reveal by the passage of time.

According to Samsung, mobile phone uses based in India and Russia have no brand preferences and they would easily accept the Tizen smart phones backed by the brand power of Samsung.

FDA Approves Blood-Clot Medication Zonitivity for Heart, Stroke

By Leave a Comment

The pharmaceutical company, Merck has created a new drug known as, Zonitivity, that can be used to diminish and reduce the chances and risks of stroke or cardiovascular death. But it is not recommended in patients who have a history of stroke or a traumatic head injury.

The FDA has recently given the company a go ahead for the new drug, Zontivity, which inhibits blood clots. It is a protease-activated receptor-1 (PAR-1) antagonist.

Produced by the American pharmaceutical manufacturer, Merch & Co., the new medication has the ability to reduce the risk of heart attacks and strokes. It will be available shortly at all major retail pharmaceutical stores by name Zontivity.

Ellis Unger, the director of FDA’s Office of Drug Evaluation I, said, “In patients who have had a heart attack or who have peripheral arterial disease, this drug will lower the risk of heart attack, stroke and cardiovascular death.”

http://www.virus.com.gr/site/media/k2/items/cache/fce01341774186a17457104171b805ae_XL.jpg

In patients with cardiovascular disease and arterial disease can take Zontivity to reduce their chances of stroke. However, when the new drug is compared with other blood-clot inhibitors in the market, Zontivity too, increases the risk of bleeding in patients by hindering platelets in the blood from clustering together. Due to these reasons, the FDA does not recommend Zontivity in patients who have suffered from a stroke or traumatic head injury, once in their life.

The approval of Zontivity has been reportedly delayed over safety concerns in patients suffering from other diseases, due to the fatal bleeding in some of the patients who were given Merck’s new medication during the clinical trials.

Zontivity will be a miracle drug for heart patients and will prevent myocardial infarction, stroke, and cardiovascular death in high-risk patients. It will improve the blood flow in patients who have had a attack or suffered from artery blockages.

Categories